BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Liu A, Peng J, Hu Y, Feng X. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib. Eur J Med Res 2015;20:12. [PMID: 25649133 DOI: 10.1186/s40001-015-0085-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Yamaoka K, Kawaoka T, Aikata H, Ando Y, Kosaka Y, Suehiro Y, Fujii Y, Uchikawa S, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Takahashi S, Saeki Y, Kuroda S, Kobayashi T, Ohdan H, Miyata Y, Okada M, Chayama K. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib. Intern Med 2021;60:2047-53. [PMID: 34193774 DOI: 10.2169/internalmedicine.5870-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Park JG, Tak WY, Park SY, Kweon YO, Jang SY, Lee SH, Lee YR, Jang SK, Hur K, Lee HJ. Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report. Oncol Lett 2017;14:4853-6. [PMID: 29085491 DOI: 10.3892/ol.2017.6788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Kim SB. Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment. Case Rep Gastroenterol 2021;15:610-5. [PMID: 34616264 DOI: 10.1159/000514529] [Reference Citation Analysis]